05/09/2026
Some of the most challenging pathologies aren’t difficult because we don’t understand the problem.
They’re difficult because there simply aren’t many good treatment options.
When traditional conservative care has provided limited relief, surgery may not be appropriate or desired, or there simply isn’t a clear next step, patients and physicians can find themselves facing a significant treatment gap.
That’s where having another option matters.
Lipogems® MicroFat provides physicians with an FDA-cleared option using the patient’s own adipose tissue. Lipogems technology washes, rinses, and progressively resizes the tissue while preserving its natural microarchitecture—creating an injectable tissue product that can provide cushioning and structural support at sites of damaged or injured tissue.
For challenging pathologies with limited conventional treatment options, expanding the physician’s toolbox can open a different conversation about what may be possible for the patient.
Not every pathology fits neatly into a traditional treatment algorithm.
Sometimes innovation matters most where options are fewest.
